Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO
Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq Global Market today. The firm
Read moreSpecial purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq Global Market today. The firm
Read more